Merck & Co., Inc. is 158.5x more valuable than Lakefront Biotherapeutics NV by market capitalization ($293.16 B vs $1.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LKFT | MRK |
|---|---|---|
| Market cap | $1.85 B | $293.16 B |
| US-listed rank | #2151 | #44 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | - | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 511 | 996 |
Merck & Co., Inc. is 158.5x more valuable than Lakefront Biotherapeutics NV by market capitalization ($293.16 B vs $1.85 B).
Full pages: Lakefront Biotherapeutics NV and Merck & Co., Inc., or browse the full rankings.